NCT04874480
Tegavivint for the Treatment of Relapsed or Refractory Leukemia treatment 1 active_not_recruiting NCT06644183
A Phase 1/2, Open Label, Study of Roginolisib (IOA-244), an Orally Bioavailable, Selective PI3Kδ Inhibitor in Patients With Refractory/Relapsed Chronic Lymphocytic Leukemia (CLL) in Combination With Venetoclax and Rituximab No drug interventions treatment 1 / 2 not_yet_recruiting NCT05305859
Venetoclax Combining Chidamide and Azacitidine (VCA) in the Treatment of R/R AML treatment 2 recruiting NCT06006403
Safety and Efficacy of CD123-targeted CAR-NK for Relapsed/Refractory Acute Myeloid Leukemia or Blastic Plasmacytoid Dendritic Cell Neoplasm treatment 1 / 2 recruiting NCT05043571
CARTALL: Chimeric-Antigen Receptor (CAR) T-Cell Therapy for Relapsed/ Refractory T-Lineage Acute Lymphoblastic Leukaemia No drug interventions treatment 1 recruiting NCT05576532
Venetoclax Plus IM2 Regimen for Relapsed and Refractory T Lymphoblastic Lymphoma/Leukemia No drug interventions treatment 2 recruiting NCT05164042
Allogeneic CD19 CAR-T Cells for the Treatment of Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia No drug interventions treatment 1 / 2 unknown_status NCT03799224
Decitabine Plus mBU/CY Preconditioning for Relapse/Refractory Acute Leukemia treatment 2 / 3 unknown_status NCT05046444
Solving Riddles Through Sequencing No drug interventions Not Available Not Available recruiting NCT05321940
Safety Trial of STING-dependent Activators and Stimulated Dendritic Cells for Aggressive Relapsed/Refractory Leukemias No drug interventions treatment 1 withdrawn NCT00880269
Efficacy and Safety of Panobinostat (LBH589) in Patients With Refractory de Novo or Secondary Acute Myelogenous Leukemia (AML) treatment 2 completed NCT05519384
Safety and Preliminary Efficacy of JK500 Cell Injection in Relapsed/Refractory Pediatric Acute Myeloid Leukemia treatment 0 recruiting NCT04470947
Comprehensive Genomic Profiling and Next Generation Functional Drug Screening for Patients With Aggressive Haematological Malignancies No drug interventions Not Available Not Available recruiting NCT04282811
Observational Study Relapsed or Refractory Chronic Lymphocytic Leukemia Venetoclax-based Regimens Outside Clinical Trials in Italy Not Available Not Available recruiting NCT04722952
PD-1 Inhibitor Combined With Azacytidine and Homoharringtonine，Cytarabine, G-CSF for Refractory or Relapsed AML treatment 3 unknown_status NCT05495035
Study for Safety and Efficacy of Olverembatinib Combined With APG-2575 in Children With Relapsed/Refractory Ph + ALL treatment 1 recruiting NCT04597086
Bright White Light Therapy for the Improvement of Sleep, Fatigue, Distress, Depression, and Anxiety in Hospitalized Leukemia Patients No drug interventions supportive_care Not Available completed NCT02512926
Carfilzomib in Combination With Cyclophosphamide and Etoposide for Children treatment 1 completed NCT04684472
Modified CD19 CAR-T in Patients With Relapsed or Refractory CD19+ B-cell Malignancies No drug interventions treatment 1 unknown_status NCT05870995
Chemotherapy CLAGE-Ven Sequential With Reduced Intensity Conditioning for Refractory Acute Myelodi Leukemia No drug interventions treatment 2 recruiting